RecruitingNot ApplicableNCT05131399

Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment

Single Case Experimental Design (SCED) Comparing an Off-the-shelf Carbon Ankle Foot Orthosis (SPRYSTEP) Versus an off-the Shelf Standard Plastic Ankle Foot Orthosis in the Treatment of Walking Functional Impairment


Sponsor

Thuasne

Enrollment

20 participants

Start Date

Feb 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to assess the superiority in achieving personal goals (set by the patient and the medical team) according to the GAS scale (Goal Attainment Scaling) while wearing the carbon medical device Ankle Foot Orthosis (AFO) compared to a standard plastic ankle foot orthosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient with a foot levator muscles impairment (single or bilateral drop foot) and / or instability of the back of the foot, associated with a deficit of the triceps
  • Patient with inability to stand on tip-toe on one foot
  • Patient having signed a free and informed consent
  • Patient affiliated or entitled to a social security scheme

Exclusion Criteria13

  • Patient with fixed varus-equine foot
  • Patient with an unstable skin condition (whether or not treated with additional treatment that may change the footwear)
  • Patient with a a foot levator muscles impairment with a deficiency of the quadriceps and hamstrings (knee involvement)
  • Patient with uncontrolled spasticity
  • Patient for whom foot surgery is planned during the study
  • Patient with one of the contraindications to the use of carbon medical device, indicated in the instructions for use
  • Patient with one of the contraindications to the use of the standard plastic ankle foot orthosis, indicated in the instructions for use
  • Patient with orthopedic comorbidities affecting the musculoskeletal system
  • Pregnant woman
  • Patient with major cognitive impairment incompatible with participation in a clinical trial
  • Patient participating in another clinical investigation conducted to establish the compliance of a MD impacting the evaluation criteria
  • Patient who cannot be followed for 12 weeks
  • Vulnerable patient according to article L1121-6 of the public health code, persons subject to a measure of judicial protection or unable to consent freely

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPhase A1

Plastic standard ankle foot orthosis

DEVICEPhase B1

carbon medical device ankle foot orthosis

DEVICEPhase A2

Plastic standard ankle foot orthosis

DEVICEPhase B2

carbon medical device ankle foot orthosis


Locations(8)

Ch Les Capucins

Angers, France

Chu Dijon

Dijon, France

CH LAVAL

Laval, France

CHU Lille

Lille, France

centre Louis PIERQUIN

Nancy, France

CHU Nantes

Nantes, France

Hôpital Rothschild

Paris, France

CHU Strasbourg

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05131399